Concepedia
Statistics
Publications
156
Citations
16.2K
H-Index
61
Active since
1975
Affiliations
University of Miami(Current)
Sylvester Comprehensive Cancer Center
University of California, Los Angeles
The University of Texas MD Anderson Cancer Center
University of Rochester
Joseph D. Rosenblatt is an author at University of Miami specializing in life sciences, oncology, and medicine.
Publications per year
1975–2025
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
Anas Younes, Ajay K. Gopal, Scott E. Smith et al. · Journal of Clinical Oncology · 2012 · 1.5K citations · Full text
Medicine, Hematology, Pharmacotherapy +17
Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
Barbara Pro, Ranjana H. Advani, Pauline Brice et al. · Journal of Clinical Oncology · 2012 · 990 citations · Full text
Medicine, Oncology, Pharmacotherapy +15
B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximab
R. John Looney, Jennifer H. Anolik, Debbie Campbell et al. · Arthritis & Rheumatism · 2004 · 777 citations
Life Sciences, Immunology, Pharmacotherapy +16
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
Caron A. Jacobson, Julio C. Chávez, Alison R. Sehgal et al. · The Lancet Oncology · 2021 · 617 citations
Medicine, Oncology, Pharmacology +13
A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
Luis E. Raez, Kyriakos P. Papadopoulos, Alejandro D. Ricart et al. · Cancer Chemotherapy and Pharmacology · 2012 · 529 citations
Medicine, Oncology, Pharmacology +12
1–5 of 156